Systematic screening and treatment evaluation of hereditary neck paragangliomas

Head and Neck

Volumn 29, Issue 9, 2007, Pages 864-873

  Fish III, John H ^a,b   Klein Weigel, Peter ^a,c   Biebl, Matthias ^a   Janecke, Andreas ^a   Tauscher, Thomas ^a   Fraedrich, Gustav ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b LERNER RESEARCH INSTITUTE   (United States)

^c German Red Cross Hospital   (Germany)

Author keywords

Carotid body tumor; Familial; Genetics; Screening; Surgery

Indexed keywords

SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE SUBUNIT D; UNCLASSIFIED DRUG;

ADULT; AGED; ALGORITHM; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; CAROTID BODY TUMOR; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FAMILIAL CANCER; FEMALE; GENE MUTATION; HEAD AND NECK CANCER; HUMAN; MALE; MORBIDITY; NECK CANCER; PARAGANGLIOMA; PRIORITY JOURNAL; REVIEW; TUMOR VOLUME; ULTRASOUND;

ALGORITHMS; CODON, NONSENSE; FEMALE; GERM-LINE MUTATION; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PARAGANGLIOMA; PEDIGREE; SUCCINATE DEHYDROGENASE; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 37349030767     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20638     Document Type: Review

References (28)

1. Mulinsky J, DeStefano AL, Huang XL, et al. Familial paragangliomas: linkage to chromosome 11q23 and clinical implications. Am J Med Genet 1997;72:66-70.
2. Cascon A, Ruiz-Llorente S, Cebrian A, et al. Identification of novel SDHD mutations in patients with phaeochromocytoma and/or paraganglioma. Eur J Hum Genet 2002;10:457-461.
3. Bikhazi PH, Roeder E, Attaie A, Lalwani AK. Familial paragangliomas: the emerging impact of molecular genetics on evaluation and management. Am J Otol 1999;20:639-643.
4. Van Baars F, van den Broek P, Cremers C, Veldman J. Familial nonchromaffinic paragangliomas (glomus tumors): clinical aspects. Laryngoscope 1981;91:988-996.
5. Netterville JL, Jackson CG, Miller FR, Wanamaker JR, Glasscock ME. Vagal paraganglioma: a review of 46 patients treated during a 20-year period. Arch Otolaryngol Head Neck Surg 1998;124:1133-1140.
6. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paragangliomas. Science 2000;287:848-851.
7. Glimm O, Armanios M, Dziema H, Neumann H, Eng C. Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res 2000;60:6822-6825.
8. Cremers CW, de Mönnink JP, Arts N, Joosten F, Kremer H, Hoefsloot L. Clinical report on the L95P mutation in a Dutch family with paraganglioma. Otol Neurotol 2002;23:755-759.
9. Struycken PM, Cremers CW, Mariman EC, Joosten FB, Bleker RJ. Glomus tumors and genomic imprinting: the influence of inheritance along the paternal or maternal line. Clin Otolaryngol 1997;22:71-76.
10. Niemann S, Steinberger D, Müller U. PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma. Neurogenetics 1999;2:167-170.
11. Niemann S, Becker-Follmann J, Nurnberg G, et al. Assignment of PGL3 to chromosome 1 (q21-q23) in a family with autosomal dominant nonchromaffin paraganglioma. Am J Med Genet 2001;98:32-36.
12. Baysal BE, Willett-Brozick JE, Lawrence EC, et al. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas. J Med Genet 2002;39:178-183.
13. Barnes L, Taylor SR. Carotid body paragangliomas. A clinicopathologic and DNA analysis of 13 tumors. Arch Otolaryngol Head Neck Surg 1990;116:447-453.
14. Kayal JD, Hampton RW. Malignant glomus tumor: a case report and review of the literature. Dermatol Surg 2001;27:837-840.
15. Lee JH, Barich F, Karnell LH, et al. National cancer data base report on malignant paragangliomas of the head and neck. Cancer 2002;94:730-737.
16. Manolidis S, Shohet JA, Jackson CG, Glasscock ME III. Malignant glomus tumors. Laryngoscope 1999;109:30-34.
17. Van der Mey AG, Frijns JH, Cornelisse CJ, et al. Does intervention improve the natural course of glomus tumors? A series of 108 patients seen in a 32-year period. Ann Otol Rhinol Laryngol 1992;101:635-642.
18. Milunsky JM, Maher TA, Michels W, Milunsky A. Novel mutations and the emergence of a common mutation in the SDHD gene causing familial paraganglioma. Am J Med Genet 2001;100:311-314.
19. Telischi FF, Bustillo A, Whiteman ML, et al. Octreotide scintigraphy for the detection of paragangliomas. Otolaryngol Head Neck Surg 2000;122:358-362.
20. Schmidt M, Fischer E, Dietlein M, et al. Clinical value of somatostatin imaging in patients with suspected head and neck paragangliomas. Eur J Nucl Med Mol Imaging 2002;29:1571-1580.
21. Bartels LJ, Gurucharri M. Pediatric glomus tumors. Otolaryngol Head Neck Surg 1988;99:392-395.
22. Baysal BE. Hereditary paraganglioma targets diverse paraganglia. J Med Genet 2002;39:617-622.
23. Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 2004;292:943-951.
24. Kohn JS, Raftery KB, Jewell ER. Familial carotid body tumors: a closer look. J Vase Surg 1999;29:649-653.
25. Netterville JL, Reilly KM, Robertson D, Reiber ME, Armstrong WB, Childs P. Carotid body tumors: a review of 30 patients with 46 tumors. Laryngoscope 1995;105:115-126.
26. Hallett JW Jr, Nora JD, Cherry KJ Jr, Pairolero PC. Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas: a fifty-year experience with 153 tumors. J Vasc Surg 1988;7:284-291.
27. Nora JD, Hallett JW Jr, O'Brien PC, Naessens JM, Cherry KJ Jr, Pairolero PC. Surgical resection of carotid body tumors: long-term survival, recurrence, and metastasis. Mayo Clinic Proc 1988;63:348-352.
28. Astrom K, Cohen JE, Willett-Brozick JE, Aston CE, Baysal BE. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum Genet 2003;113:228-237.